[1] |
Guthrie RA, Guthrie DW. Pathophysiology of diabetes mellitus[J]. Crit Care Nurs Q, 2004, 27(2): 113-125.
|
[2] |
Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues[J]. Free Radic Biol Med, 1996, 20(3): 463-466.
|
[3] |
Kehm R, J?hnert M, Deubel S, et al. Redox homeostasis and cell cycle activation mediate beta-cell mass expansion in aged, diabetes-prone mice under metabolic stress conditions: role of thioredoxin-interacting protein (TXNIP)[J]. Redox Biol, 2020, 37: 101748.
|
[4] |
Chen JQ, Couto FM, Minn AH, et al. Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein[J]. Biochem Biophys Res Commun, 2006, 346(3): 1067-1074.
|
[5] |
Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression[J]. J Biol Chem, 1999, 274(31): 21645-21650.
|
[6] |
Junn E, Han SH, Im JY, et al. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function[J]. J Immunol, 2000, 164(12): 6287-6295.
|
[7] |
Schulze PC, Yoshioka J, Takahashi T, et al. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein[J]. J Biol Chem, 2004, 279(29): 30369-30374.
|
[8] |
Shalev A, Pise-Masison CA, Radonovich M, et al. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway[J]. Endocrinology, 2002, 143(9): 3695-3698.
|
[9] |
Shalev A. Lack of TXNIP protects beta-cells against glucotoxicity[J]. Biochem Soc Trans, 2008, 36(Pt 5): 963-965.
|
[10] |
Thielen LA, Chen JQ, Jing G, et al. Identification of an anti-diabetic, orally available small molecule that regulates TXNIP expression and glucagon action[J]. Cell Metab, 2020, 32(3): 353-365.
|
[11] |
Zheng S, Chen NX, Kang XJ, et al. Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway[J]. Endocrine, 2022, 75(3):740-751.
|